Compared with older pharmacologic options, GLP-1 receptor agonists and newer incretin-based therapies generally offer greater average weight reduction, but they also raise specific issues related to gastrointestinal tolerability, long-term continuation, affordability, and access ( 6 Safety and practical prescribing considerations in KOA patients Safety considerations are particularly important when GLP-1 receptor agonists are considered for patients with obesity-related KOA, because this population often includes older adults, patients with multimorbidity, and individuals approaching elective arthroplasty
GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances insulin secretion, supports fat metabolism
Louzana Will the collegen clog arteries
James Egan: Ellen, thank you for all your insights
Payment processing is straightforward
If side effects have taken a toll on your teeth, were here to restore your smile with dentures, implants, or custom solutions, so you dont lose confidence along the way. -Crown & Denture Solutions Team Ready to Protect Your Smile
